Skip to main content
Home
  • About
    • Board of Directors
    • Our Staff
    • Annual Reports
      • 2018 Annual Report
      • 2021 Annual Report
      • 2017 Annual Report
    • Policies
    • Careers
    • Programs
      • COVID-19 Hub
      • Antimicrobial Use Data in Food Animals
      • Food & Nutrition
      • Research
        • About IMEDS
        • IMEDS Network Partners
        • IMEDS Populations
        • IMEDS Steering Committee
        • Post Market Research
        • Real World Evidence
        • Real-World Data Webinars
        • IMEDS News Archive
      • Expanded Access Navigator
      • Substance Use Disorders
      • FDA Patient Listening Sessions
    • News and Events
      • 2022 Annual Public Meeting
      • News
      • Events
      • Innovations in Regulatory Science Awards
    • COVID-19
    • facebook
    • twitter
    • linkedin
    • youtube
    Home
    • About
      • Board of Directors
      • Our Staff
      • Annual Reports
      • Policies
      • Careers
    • Programs
      • COVID-19 Hub
      • Antimicrobial Use Data in Food Animals
      • Food & Nutrition
      • Research
      • Expanded Access Navigator
      • Substance Use Disorders
      • FDA Patient Listening Sessions
    • News and Events
      • 2022 Annual Public Meeting
      • News
      • Events
      • Innovations in Regulatory Science Awards
    • COVID-19

    News

    Breadcrumb

    1. Home
    2. News and Events
    3. In Brief - The Cancer Letter
    • facebook
    • twitter
    • email
    • print

    In Brief - The Cancer Letter

    • Reagan-Udall receives $250,000 from Rockefeller Foundation for COVID-19 Diagnostics Evidence Accelerator

     

     

    Read more

    Subscribe for updates from the Reagan-Udall Foundation for the FDA

    Subscribe
    (202) 849 - 2075
    1333 New Hampshire Ave, NW
    Suite 420
    Washington, DC 20036
    admin@reaganudall.org
    • facebook
    • twitter
    • linkedin
    • youtube
    © Reagan-Udall Foundation for the FDA
    © Reagan-Udall Foundation for the FDA